Related Experiment Video
Updated: Jul 18, 2026

Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
Differentiation of gastric ulcers with MDCT
Chiao-Yun Chen1, Twei-Shiun Jaw, Yu-Ting Kuo
1Department of Radiology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung City, Taiwan.
Abstract:
It is important to differentiate malignant from benign gastric ulcers (GUs) because the early detection of malignancy offers the best prognosis and is essential for planning optimal therapy. However, the differential diagnosis between a malignant and benign gastric ulcer is sometimes difficult, and remains a great challenge. Recent advances in multidetector row-computed tomography (MDCT) with three-dimensional imaging software and multiplanar reformatted (MPR) images provide a potentially powerful tool for noninvasive gastric evaluation. Virtual gastroscopy (VG) is helpful in the detection and evaluation of GU in the same way as gastroscopy. In comparison with gastroscopy, VG images can depict abnormal endoluminal lesions with a wider field of view and they have no blind point because retrospective reconstruction is available. MPR images allow the radiologist to choose the optimal imaging plane to accurately evaluate the change of the gastric wall around the gastric ulcer avoiding partial volume averaging effects. This report describes the clinical usefulness of MDCT in differentiating malignant from benign GUs by using VG and MPR images.
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease III: Clinical Manifestations and Complications
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease II: Pathophysiology
